| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 36,600 | 36,800 | 10.11. | |
| 36,400 | 37,000 | 10.11. |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 38,000 | 1.370 | |||
| 37,800 | 13 | |||
| 37,600 | 1.370 | |||
| 37,400 | 13 | |||
| 37,200 | 2.996 | |||
| 37,000 | 1.639 | |||
| 36,800 | 4.161 | |||
| 36,600 | 524 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/l10.htm [/URL] | ||||
| 524 | 36,400 | |||
| 3.957 | 36,200 | |||
| 1.841 | 36,000 | |||
| 1.639 | 35,800 | |||
| 1.370 | 35,600 | |||
| 13 | 35,400 | |||
| 1.370 | 35,200 | |||
| 13 | 35,000 | |||
| 1.370 | 34,800 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 12.097 | 0,999 | 12.086 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
Keine Umsätze verfügbar. | ||
| Tagesumsatz Xetra | +0,600 +1,67 % | 0 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MEDLINE Aktie jetzt für 0€ handeln | |||||
| Sa | Billionaire Hedge Fund Manager Calls Medline (MDLN) a Category Killer Despite a Frustrating Year | 12 | Insider Monkey | ||
| 04.11. | Medline Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 04.11. | Medline outlines 2027 high single-digit net sales growth while launching a $1B share repurchase program | 2 | Seeking Alpha | ||
| 04.11. | Medline Q3 2026 slides: sales rise 10%, shares jump 15% on guidance | 2 | Investing.com | ||
| 04.11. | Medline plans to increase prices in 2027 to offset inflation pressures, reports strong Q3 results | 1 | MassDevice |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Di | Innovation and Product Launch Momentum Drive Alcon's Third-Quarter 2026 Growth | Business Wire | Third-quarter 2026 sales of $2.7 billion, +5%, +5% constant currency1 (cc), vs. third-quarter 2025 Year-to-date 2026 sales of $8.2 billion, +7%, +6% cc, vs. the same period last year ... ► Artikel lesen | |
| Di | EQS-PVR: Fresenius Medical Care AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Group (EN) | EQS Voting Rights Announcement: Fresenius Medical Care AG
Fresenius Medical Care AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act]... ► Artikel lesen | |
| Di | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2027 Financial Results, Delivering First-ever Net Income Before Income Tax | ACCESS Newswire | Total revenue increased 28% for the quarter and 41% for the six months ended September 30, 2026 compared to same periods last yearU.S. revenue increased 93% for the quarter and 113% for the six months... ► Artikel lesen | |
| Di | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | PR Newswire | SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other... ► Artikel lesen | |
| Di | ROUNDUP: Olympus Corp. H1 Profit Soars; Raises FY Outlook | AFX News | TOKYO (dpa-AFX) - Olympus Corp. (OCPNF, 7733.T), a Japanese medical technology company, reported Tuesday significantly higher earnings for the first half on higher revenue. Further, the company... ► Artikel lesen |